The susceptibility CDKN2 locus may have a role on prognosis of melanoma patients.
Casula
M
M
Institute of Biomolecular Chemistry, National Research Council, Sassari.
Budroni
M
M
Department of Epidemiology, Local Health Unit 1, Sassari.
Cossu
A
A
Department of Pathology, Hospital-University Health Unit, Sassari.
Ascierto
P A
PA
Melanoma Unit, National Cancer Institute-Fondazione Pascale, Naples.
Mozzillo
N
N
Melanoma Unit, National Cancer Institute-Fondazione Pascale, Naples.
Canzanella
S
S
House Hospital Onlus Nonprofit Organization, Naples.
Muggiano
A
A
Medical Oncology, Regional Cancer Hospital-Businco, Cagliari, Italy.
Palmieri
G
G
Institute of Biomolecular Chemistry, National Research Council, Sassari. Electronic address: gpalmieri@yahoo.com.
D005500:Follow-Up Studies; D019942:Genes, p16 / Q000502:physiology*; D020022:Genetic Predisposition to Disease; D055106:Genome-Wide Association Study; D005838:Genotype; D006801:Humans; D008545:Melanoma / Q000175:diagnosis* / Q000235:genetics / Q000401:mortality; D020641:Polymorphism, Single Nucleotide; D011379:Prognosis; D012878:Skin Neoplasms / Q000175:diagnosis* / Q000235:genetics / Q000401:mortality; D016019:Survival Analysis